» Articles » PMID: 16644726

Regulation of Rat Hepatic L-pyruvate Kinase Promoter Composition and Activity by Glucose, N-3 Polyunsaturated Fatty Acids, and Peroxisome Proliferator-activated Receptor-alpha Agonist

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2006 Apr 29
PMID 16644726
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

Carbohydrate regulatory element-binding protein (ChREBP), MAX-like factor X (MLX), and hepatic nuclear factor-4alpha (HNF-4alpha) are key transcription factors involved in the glucose-mediated induction of hepatic L-type pyruvate kinase (L-PK) gene transcription. n-3 polyunsaturated fatty acids (PUFA) and WY14643 (peroxisome proliferator-activated receptor alpha (PPARalpha) agonist) interfere with glucose-stimulated L-PK gene transcription in vivo and in rat primary hepatocytes. Feeding rats a diet containing n-3 PUFA or WY14643 suppressed hepatic mRNA(L-PK) but did not suppress hepatic ChREBP or HNF-4alpha nuclear abundance. Hepatic MLX nuclear abundance, however, was suppressed by n-3 PUFA but not WY14643. In rat primary hepatocytes, glucose-stimulated accumulation of mRNA(LPK) and L-PK promoter activity correlated with increased ChREBP nuclear abundance. This treatment also increased L-PK promoter occupancy by RNA polymerase II (RNA pol II), acetylated histone H3 (Ac-H3), and acetylated histone H4 (Ac-H4) but did not significantly impact L-PK promoter occupancy by ChREBP or HNF-4alpha. Inhibition of L-PK promoter activity by n-3 PUFA correlated with suppressed RNA pol II, Ac-H3, and Ac-H4 occupancy on the L-PK promoter. Although n-3 PUFA transiently suppressed ChREBP and MLX nuclear abundance, this treatment did not impact ChREBP-LPK promoter interaction. HNF4alpha-LPK promoter interaction was transiently suppressed by n-3 PUFA. Inhibition of L-PK promoter activity by WY14643 correlated with a transient decline in ChREBP nuclear abundance and decreased Ac-H4 interaction with the L-PK promoter. WY14643, however, had no impact on MLX nuclear abundance or HNF4alpha-LPK promoter interaction. Although overexpressed ChREBP or HNF-4alpha did not relieve n-3 PUFA suppression of L-PK gene expression, overexpressed MLX fully abrogated n-3 PUFA suppression of L-PK promoter activity and mRNA(L-PK) abundance. Overexpressed ChREBP, but not MLX, relieved the WY14643 inhibition of L-PK. In conclusion, n-3 PUFA and WY14643/PPARalpha target different transcription factors to control L-PK gene transcription. MLX, the heterodimer partner for ChREBP, has emerged as a novel target for n-3 PUFA regulation.

Citing Articles

Biochemical characterization and discovery of inhibitors for Sir2A: new tricks for an old enzyme.

Donu D, Boyle E, Curry A, Cen Y RSC Chem Biol. 2025; 6(3):438-448.

PMID: 39897407 PMC: 11784564. DOI: 10.1039/d4cb00206g.


Berberine ameliorates glucocorticoid-induced hyperglycemia: an in vitro and in vivo study.

Gupta M, Rumman M, Singh B, Mahdi A, Pandey S Naunyn Schmiedebergs Arch Pharmacol. 2023; 397(3):1647-1658.

PMID: 37704773 DOI: 10.1007/s00210-023-02703-2.


Modification of a Constitutive to Glucose-Responsive Liver-Specific Promoter Resulted in Increased Efficacy of Adeno-Associated Virus Serotype 8-Insulin Gene Therapy of Diabetic Mice.

Sia K, Fu Z, Calne R, Nathwani A, Lee K, Gan S Cells. 2020; 9(11).

PMID: 33202992 PMC: 7696068. DOI: 10.3390/cells9112474.


Physiological effects of an oil rich in γ-linolenic acid on hepatic fatty acid oxidation and serum lipid levels in genetically hyperlipidemic mice.

Ide T, Origuchi I J Clin Biochem Nutr. 2019; 64(2):148-157.

PMID: 30936627 PMC: 6436035. DOI: 10.3164/jcbn.18-64.


Omega-3 polyunsaturated fatty acids as a treatment strategy for nonalcoholic fatty liver disease.

Jump D, Lytle K, Depner C, Tripathy S Pharmacol Ther. 2017; 181:108-125.

PMID: 28723414 PMC: 5743581. DOI: 10.1016/j.pharmthera.2017.07.007.


References
1.
Oddos J, Grange T, Carr K, Matthews B, Roux J, Richard-Foy H . Nucleotide sequence of 10 kilobases of rat tyrosine aminotransferase gene 5' flanking region. Nucleic Acids Res. 1989; 17(21):8877-8. PMC: 335070. DOI: 10.1093/nar/17.21.8877. View

2.
Pan D, Mater M, Thelen A, Peters J, Gonzalez F, Jump D . Evidence against the peroxisome proliferator-activated receptor alpha (PPARalpha) as the mediator for polyunsaturated fatty acid suppression of hepatic L-pyruvate kinase gene transcription. J Lipid Res. 2000; 41(5):742-51. View

3.
Amy C, Naggert J, Smith S . Molecular cloning of the mammalian fatty acid synthase gene and identification of the promoter region. Biochem J. 1990; 271(3):675-9. PMC: 1149615. DOI: 10.1042/bj2710675. View

4.
Stoeckman A, Towle H . The role of SREBP-1c in nutritional regulation of lipogenic enzyme gene expression. J Biol Chem. 2002; 277(30):27029-35. DOI: 10.1074/jbc.M202638200. View

5.
Eilers A, Sundwall E, Lin M, Sullivan A, Ayer D . A novel heterodimerization domain, CRM1, and 14-3-3 control subcellular localization of the MondoA-Mlx heterocomplex. Mol Cell Biol. 2002; 22(24):8514-26. PMC: 139889. DOI: 10.1128/MCB.22.24.8514-8526.2002. View